Clinical Trial Update: IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating IH636 grape seed extract for preventing breast cancer in postmenopausal women at risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IH636 Grape Seed Extract (grape seed extract)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED